Stocks · Health care · Pharmaceutical Preparations

Merck & Co.

MRK Clue Score53
United States Fiscal year ends December CIK 0000310158 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Jennifer Zachary
12 Aug 2026
EVP, General Counsel
Sold after exercise
80,315
$133.46
$10.72M
David Michael Williams
5 Aug 2026
EVP,Chief Info&Digital Officer
Sold after exercise
34,705
$128.77
$4.47M
David Michael Williams
5 Aug 2026
EVP,Chief Info&Digital Officer
Sold after exercise
13,542
$128.77
$1.74M
David Michael Williams
5 Aug 2026
EVP,Chief Info&Digital Officer
Sold after exercise
4,600
$128.77
$592.35K
David R. Maraldo
5 Aug 2026
EVP & Pres. MMD
Sold after exercise
2,686
$128.72
$345.74K
David R. Maraldo
5 Aug 2026
EVP & Pres. MMD
Sold after exercise
9,709
$128.72
$1.25M
David R. Maraldo
5 Aug 2026
EVP & Pres. MMD
Sold after exercise
6,311
$128.72
$812.34K
Jennifer Zachary
9 Feb 2026
EVP, General Counsel
Sold after exercise
38,835
$119.15
$4.63M
Jennifer Zachary
9 Feb 2026
EVP, General Counsel
Sold after exercise
56,792
$119.15
$6.77M
Jennifer Zachary
9 Feb 2026
EVP, General Counsel
Sold after exercise
25,946
$119.15
$3.09M
David Michael Williams
6 Feb 2026
EVP,Chief Info&Digital Officer
Sold after exercise
5,000
$121.91
$609.53K
Dean Y Li
4 Feb 2026
Executive VP & President, MRL
Sold after exercise
15,087
$118.77
$1.79M
Caroline Litchfield
4 Feb 2026
EVP & CFO
Sold after exercise
41,997
$119.61
$5.02M
Dalton E. Smart III
4 Feb 2026
SVP Fin. - Global Controller
Sold after exercise
2,400
$119.68
$287.22K
Dalton E. Smart III
4 Feb 2026
SVP Fin. - Global Controller
Sold after exercise
4,000
$119.68
$478.70K

What was left out

Form 4 filings counted 81
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 15
Sales at will 19
Transactions with no price 0
Shares from compensation/vesting 537,512
History held since 25 Oct 2006